Access Now

Look up NPI Number
CE InformationCourse Progress
  • Pre-Test
  • Access Webinar
  • Download PDF of Slides
  • Evaluation
  • Certificate
Evaluation

Recent Advances in Prostate Cancer: Strategies to Improve Screening and Multidisciplinary Care

Evaluation

HMP Education would appreciate your feedback on the quality and impact of this activity.

Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little).

To what extent are you able to better achieve each of the following learning objectives?

Summarize the advantages and limitations of current PC screening and diagnostic tools, including PSA, Gleason score, NGI, and MCED tests
Assess guideline recommendations, shared decision-making, and updated strategies for clinical practice to improve PC diagnosis and outcomes
Develop multidisciplinary care strategies to facilitate the timely referral of patients to appropriate PC specialists

Please rate the faculty on their knowledge, expertise, and teaching ability (5= excellent, 3 = good, 1 = poor).

Matt Rosenberg, MD
Neal Shore, MD, FACS

Please rate the following components relating to this activity:

Content
Relevance to your practice 
Educational format 
Audience-participation portions (eg., Q&A, polling, pre/post-testing) 
Resources and/or other materials supporting the activity
Overall

Therapeutic recommendations presented in this activity did not encourage inappropriate or excessive use of products/devices.

How many patients with PC do you see during a typical month?

Do you feel like there were any new data presented?

Did you learn anything new?

Did you gain confidence on the new information?

Did this program include opportunities to learn as a part of a healthcare team?

What proportion of men screened for prostate cancer (PC) receive false positive PSA test results?

Which of the following imaging strategies plays a central role in the diagnosis of clinically significant PC by determining classification and obtaining a targeted biopsy?

Upon his annual visit, your 71-year-old African American patient has been feeling fatigued recently and is concerned that his PC has returned. His PC was effectively treated with surgery 3 years prior. His type 2 diabetes is well- controlled, and he has no history of smoking or family history of PC. His PSA value is 0.8. How should you proceed with this patient?

Please rate your ability to screen for PC:

Do you intend to make any additional changes to your practice as a result of information gained from this activity? Please be specific.

What challenges or barriers outside of your control may prevent you from changing your practice?
255 characters max

The information presented in this activity did not serve to advance a proprietary interest of any commercial entity.

Based on my participation in this activity, I anticipate I will more often (select all that apply):